Nachrichten zur Merck KGaA Aktie

MRK Up More Than 7% on Improved Long-Term Prospects: Still a Sell?

Merck stock has risen more than 7% in a month on a stronger long-term outlook, but 2026 headwinds, Keytruda patent…

Pharmabranche: Sanofi trennt sich von CEO – scheidende Merck-Chefin Garijo übernimmt

Nach 15 Jahren beim deutschen Pharmakonzern Merck wechselt Belén Garijo zum französischen Konkurrenten Sanofi. Der Vertrag ihres Vorgängers wird nicht…

Exelixis (EXEL) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.DateTuesday, February 10, 2026 at 5:00 p.m. ETCall participantsPresident and Chief Executive Officer — Michael MorrisseyChief…

FDA approves Merck’s Keytruda for ovarian cancer treatment By Investing.com

FDA approves Merck’s Keytruda for ovarian cancer treatment…

Merck: The Spike Doesnt Make It Overvalued

…

Merck Overweight

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA mit einem Kursziel von 150 Euro…

From Bargain To Balancing Act: Mercks Next Test Begins (Rating Downgrade)

…

Merck: Pipeline Building Despite The Light FY26 Guide, Major Momentum

…

Insider trades: Merck, Intel, Micron among notable names

…

Mercks Subdued 2026 Outlook: What it Means After Q4 Results?

MRK posts conservative 2026 sales and EPS outlook, given acquisition charges. Keytruda, Animal Health and new drug launches are expected…

Merck veteran Perlmutter-led Eikon ?Therapeutics valued at $860 million in Nasdaq debut

Drug developer Eikon Therapeutics , headed by Merck veteran Roger Perlmutter, was valued at about $860.3 million after its shares…

Amgen (AMGN) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.DATETuesday, Feb. 3, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChairman, President & Chief Executive Officer — Robert…

Will Merck KGaA (MKKGY) Beat Estimates Again in Its Next Earnings Report?

Merck KGaA (MKKGY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…

Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms

Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off…

Merck Kaufen

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für Merck KGaA auf "Kaufen" mit einem fairen Wert von…

Merck and Pfizer decline vs the broader market as results released

The pharma industry is handling big transitions, as highlighted in Mercks and Pfizers earnings, released Tuesday…

+++ Geschäftszahlen +++: Sartorius erreicht Ziele für 2025 – Wachstum erwartet

Paypal verfehlt Erwartungen +++ US-Pharmakonzern Merck korrigiert Ausblick nach unten +++ Nintendo verfehlt Gewinnerwartungen trotz Switch-2-Absatz +++ Der Newsblog.…

DZ Bank belässt Merck KGaA auf Kaufen - Fairer Wert 150 Euro

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für Merck KGaA auf "Kaufen" mit einem fairen Wert von…

Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more

These are the stocks posting the largest moves in early trading.…

Merck forecasts 2026 sales below estimates on patent losses

Merck & Co on Tuesday forecast 2026 sales and profits below Wall Street estimates as the loss of patent exclusivity…

Merck shares dip as 2026 outlook misses Wall Street expectations

Merck & Co Inc (NYSE:MRK, XETRA:6MK) shares fell 2% at Tuesday’s opening bell after the drugmaker issued a 2026 outlook…

BARCLAYS stuft MERCK KGAA auf Equal Weight

LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Merck KGaA mit einem Kursziel von 130 Euro…

MRK Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 26 View

Merck tops Q4 EPS and sales estimates as Keytruda drives growth, but shares fall in pre-market trading as 2026 guidance…

Investor Joe Terranova likes Merck despite pharmaceutical firms move to lower drug price

Merck will report its earnings on Tuesday, offering insights into how its agreement to lower the price of its diabetes…

Merck (MRK) Advances While Market Declines: Some Information for Investors

Merck (MRK) reached $110.42 at the closing of the latest trading day, reflecting a +1.92% change compared to its last…

Why the Market Dipped But Merck (MRK) Gained Today

Merck (MRK) closed at $108.34 in the latest trading session, marking a +1.35% move from the prior day.…

Führungswechsel: Merck beruft Benjamin Hein zum neuen Chef der Elektroniksparte

Der vorherige Service-Geschäft-Leiter löst zum 1. Mai Kai Beckmann ab. Der Personalwechsel räumt auch auch dessen angekündigten Weg an die…

Curious about Merck (MRK) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Looking beyond Wall Streets top-and-bottom-line estimate forecasts for Merck (MRK), delve into some of its key metrics to gain a…

Mercks Non-Oncology Drugs Q4 Performance: What to Expect

MRKs focus shifts beyond Keytruda in Q4 as investors watch new products Capvaxive and Winrevair, as well as Animal Health…

Merck ends acquisition talks with Revolution Medicines

Merck ends acquisition talks with Revolution Medicines - WSJ…

Merck (MRK) Rises Higher Than Market: Key Facts

Merck (MRK) concluded the recent trading session at $111.11, signifying a +1.52% move from its prior days close.…

Will Weak Gardasil Sales Continue to Ail MRK Revenues in Q4 Earnings?

Gardasils sharp sales slump in China and Japan puts Merck under pressure heading into Q4 earnings, with the vaccines sales…

EQS-News: Merck und ChemLex unterzeichnen Absichtserklärung zur Förderung der automatisierten Chemie und technologischen Innovation (deutsch)

Merck und ChemLex unterzeichnen Absichtserklärung zur Förderung der automatisierten Chemie und technologischen Innovation^EQS-News: ChemLex / Schlagwort(e): VertragMerck und ChemLex unterzeichnen…

dpa-AFX ProFeed